Melissa B. Epperly, Director of Nautilus Biotechnology NAUT, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/18.

ME

ME

Melissa B. Epperly

Director

Company

Nautilus Biotechnology NAUT

First filing

23/02/14

Trades

43 trades

Buys / sales

0 / 7

12-month net buying

−$1.2M

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Roivant SciencesROIV	Open-market sale	03/16	03/18	41,861 sh	$28.68	$1,200,573.48	−72.6%
Zentalis PharmaceuticalsZNTL	Open-market sale	24/02/12	24/02/12	2,573 sh	$11.44	$29,435.12	−0.6%
Zentalis PharmaceuticalsZNTL	Open-market sale	24/02/02	24/02/05	8,669 sh	$11.54	$100,040.26	−1.9%
Zentalis PharmaceuticalsZNTL	Open-market sale10b5-1 plan	23/10/04	23/10/06	5,482 sh2 trades	$19.51avg.	$106,941.5	−1.4%
Zentalis PharmaceuticalsZNTL	Open-market sale	23/02/13–23/02/14	23/02/14	7,851 sh2 trades	$20.13avg.	$158,017.54	−2.0%